$CTGO
Contango ORE, Inc.

2016 Q2 Form 10-K Financial Statement

#000143774917015979 Filed on September 15, 2017

View on sec.gov

Income Statement

Concept 2016 Q2 2016 2015 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $270.0K $1.220M $280.0K
YoY Change -3.57% -52.35% -39.13%
% of Gross Profit
Research & Development $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -96.15%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $270.0K $1.220M $290.0K
YoY Change -6.9% -58.27% -60.27%
Operating Profit
YoY Change
Interest Expense $0.00 -$1.270M
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$270.0K -$1.220M -$1.560M
YoY Change -82.69% -66.18% 113.7%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$270.0K -$1.220M -$1.560M
YoY Change -82.69% -66.18% 113.7%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$68.18K -$310.6K -$402.1K
COMMON SHARES
Basic Shares Outstanding 3.959M shares 3.876M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.250M $1.254M $1.950M
YoY Change -35.9% -35.57% -43.48%
Cash & Equivalents $1.254M $1.947M
Short-Term Investments
Other Short-Term Assets $60.00K $58.17K $70.00K
YoY Change -14.29% -13.67% -30.0%
Inventory
Prepaid Expenses $175.8K $67.38K
Receivables
Other Receivables
Total Short-Term Assets $1.313M $1.313M $2.014M
YoY Change -34.84% -34.84% -43.21%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $1.313M $1.313M $2.014M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.313M $1.313M $2.014M
YoY Change -34.84% -34.84% -59.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.85K $20.85K $24.88K
YoY Change -16.17% -16.2% -82.25%
Accrued Expenses $92.88K $92.88K $78.10K
YoY Change 18.92% 18.92% 67.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $113.7K $113.7K $103.0K
YoY Change 10.45% 10.45% -44.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $113.7K $113.7K $103.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $110.0K $113.7K $100.0K
YoY Change 10.0% 10.45% -47.37%
SHAREHOLDERS EQUITY
Retained Earnings -$32.28M -$31.06M
YoY Change 3.93% 13.14%
Common Stock $33.47M $32.97M
YoY Change 1.54% 2.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $0.00
Shareholders Equity $1.199M $1.199M $1.911M
YoY Change
Total Liabilities & Shareholders Equity $1.313M $1.313M $2.014M
YoY Change -34.84% -34.84% -59.56%

Cashflow Statement

Concept 2016 Q2 2016 2015 Q2
OPERATING ACTIVITIES
Net Income -$270.0K -$1.220M -$1.560M
YoY Change -82.69% -66.18% 113.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$90.00K -$692.6K -$110.0K
YoY Change -18.18% -53.87% -77.55%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.080M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -90.00K -$692.6K -110.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 5.080M 0.000
Net Change In Cash -90.00K -$692.6K -110.0K
YoY Change -18.18% -53.87% -77.55%
FREE CASH FLOW
Cash From Operating Activities -$90.00K -$692.6K -$110.0K
Capital Expenditures $0.00
Free Cash Flow -$110.0K
YoY Change -77.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 ctgo Acquisition Costs Mining Properties Period Cost
AcquisitionCostsMiningPropertiesPeriodCost
CY2016 ctgo Acquisition Costs Mining Properties Period Cost
AcquisitionCostsMiningPropertiesPeriodCost
CY2017 ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
0
CY2016 ctgo Costs Of Unproved Properties Excluded From Amortization Mining Properties Period Cost
CostsOfUnprovedPropertiesExcludedFromAmortizationMiningPropertiesPeriodCost
14425
CY2017Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
8747508
CY2016Q2 ctgo Deferred Tax Assets Capitalized Exploration
DeferredTaxAssetsCapitalizedExploration
8699117
CY2017 ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
CY2016 ctgo Exploration Costs And Claim Rentals Mining Properties Period Cost
ExplorationCostsAndClaimRentalsMiningPropertiesPeriodCost
14425
CY2017Q2 ctgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2017Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
845999
CY2016Q2 ctgo Options And Warrants Outstanding
OptionsAndWarrantsOutstanding
1635999
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Document Type
DocumentType
10-K
CY2016Q4 dei Entity Public Float
EntityPublicFloat
43462980
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
50858
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20854
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86561
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92884
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
40500239
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33434899
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
207400
CY2017Q2 us-gaap Assets
Assets
5367540
CY2016Q2 us-gaap Assets
Assets
1312654
CY2017Q2 us-gaap Assets Current
AssetsCurrent
5367540
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
470561
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14252083
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13073059
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4921163
CY2016Q2 us-gaap Assets Current
AssetsCurrent
1312654
CY2017 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; text-indent: 24pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America.</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; color: rgb(0, 0, 0); text-indent: 24pt; font-size: 10pt; background-color: rgb(255, 255, 255);"></div> <div style=" margin: 0pt; text-align: justify; color: rgb(0, 0, 0); text-indent: 24pt; font-size: 10pt; background-color: rgb(255, 255, 255);">These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future. Since the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s primary business is now the investment in and management of the Joint Venture Company, it expects that its ongoing cash requirements will only be related to general and administration expenses. Given this, the Company believes that its current cash balances will be sufficient to meet its working capital requirements for the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months from the date of this report.</div></div></div>
CY2017 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
CY2016 us-gaap Carrying Costs Property And Exploration Rights
CarryingCostsPropertyAndExplorationRights
14425
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1254489
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1947046
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5191749
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3937260
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-692557
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
845999
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4930231
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3958540
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3958540
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
49303
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
39585
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
2836453
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
1220218
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2017Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3260495
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1960389
CY2017Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
2118225
CY2016Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
1942992
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
125855
CY2017Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2016Q2 us-gaap Equity Method Investments
EquityMethodInvestments
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5080100
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1142840
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-692557
CY2016Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2836453
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1205793
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2836453
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1220218
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1178992
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
418777
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-992759
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-427076
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
30213
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
70540
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-41218
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-175228
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-62241
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23681
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10758
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
117626
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9219
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5367540
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1312654
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
137419
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
113738
CY2017Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-2836453
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-1220218
CY2017Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9.30
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
207400
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175791
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58165
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5287500
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2016 us-gaap Profit Loss
ProfitLoss
-1220218
CY2017 us-gaap Profit Loss
ProfitLoss
-2836453
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35112021
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32275568
CY2010Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1600000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
5230121
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
9068
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
207400
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1787558
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
507684
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
21400
CY2017 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
5287500
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
507684
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1787558
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
1911450
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1198916
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; text-indent: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Management Estimates.</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">.</div></div></div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4608177
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3928327

Files In Submission

Name View Source Status
0001437749-17-015979-index-headers.html Edgar Link pending
0001437749-17-015979-index.html Edgar Link pending
0001437749-17-015979.txt Edgar Link pending
0001437749-17-015979-xbrl.zip Edgar Link pending
a2015ph1ddhwithzones12.jpg Edgar Link pending
a2015ph2ddhwithzones1.jpg Edgar Link pending
a2016phase1explorationprogra.jpg Edgar Link pending
audreport.jpg Edgar Link pending
conta20170630_10k.htm Edgar Link pending
ctgo-20170630.xml Edgar Link completed
ctgo-20170630.xsd Edgar Link pending
ctgo-20170630_cal.xml Edgar Link unprocessable
ctgo-20170630_def.xml Edgar Link unprocessable
ctgo-20170630_lab.xml Edgar Link unprocessable
ctgo-20170630_pre.xml Edgar Link unprocessable
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex99-10.htm Edgar Link pending
ex99-8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gradexthicknessmainpeakandno.jpg Edgar Link pending
phaseiiimap.jpg Edgar Link pending
phaseiimapwallholes.jpg Edgar Link pending
phaseimap.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tetlinmap-phaseii2016program.jpg Edgar Link pending
tetlinmap1082015a01.jpg Edgar Link pending